FCF YoY
+49.23%
OCF YoY
+7.63%
Capex YoY
-28.07%
FCF Conversion Δ
+17.9 pp
Free cash flow bridge for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: $151M
FCF bridge breakdown for West Pharmaceutical Services (WST) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | $307M | — |
| Operating Cash Flow | $50.7M | +33.6% |
| Capital Expenditure | $100M | +66.4% |
| Free Cash Flow | $458M | — |
- Prior Free Cash Flow$307M
- Operating Cash Flow$50.7M
- Capital Expenditure$100M
- Free Cash Flow$458M
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.65% TTM
- Dividend Profile0.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.